Here is a question people rarely ask until they are already on the couch with numbing cream on: in England, right now, who is legally allowed to drive needle electrodes several millimetres into your face and run radiofrequency through the tissue at the bottom of them?
Short answer: no national rule says. None. That usually lands badly, because everyone assumes something this medical is already licensed. The Government has proposed changing it. Nothing has changed yet. So this is an article about a gap: what is true today, what is proposed, and how far apart the two still are. The gap is where you are booking.
Who can legally perform Morpheus8 in England today?
Start with the flat version. There is currently no national licensing scheme in force for non-surgical cosmetic procedures in England. Not in a transition period. Not in force.
The power to create one already exists, under section 180 of the Health and Care Act 2022. It has been sitting there, unused.
Three things follow, and none are what people expect.
First, Morpheus8 delivered as an aesthetic procedure by a non-clinician is not, in itself, a Care Quality Commission registrable activity. Registration turns on whether a provider carries on a regulated activity as defined in the CQC’s scope of registration guidance, which clinics working under doctors or nurses should check directly.
Second, there is no agreed operator qualification. The JCCP’s paper on energy based devices recommends standardised clinical training and adverse event reporting, and stops short of setting an operator qualification level for radiofrequency microneedling. Nobody has set the bar, so nobody is formally below it.
Third, what does exist is premises licensing, and it is a patchwork. In Greater London, premises offering special treatments need a licence under Part II of the London Local Authorities Act 1991, and boroughs commonly list electrical treatments, including radiofrequency machines, as licensable. Outside London there is no single equivalent: councils may still require a massage and special treatment premises licence, and only yours can tell you. If you are weighing up London against booking closer to home, that is a real difference, and it is about the building, not the person or the machine.
Two regulators, two completely different questions
One set of rules governs the machine. A different set governs the human holding it. In England, only the first is properly in place.
The machine side belongs to the MHRA. Devices placed on the Great Britain market must be registered with it, and a manufacturer based outside the UK has to appoint a UK Responsible Person. CE marks were accepted in Great Britain until 30 June 2023 with UKCA marking required after that, though later legislation has amended those deadlines, and EU medical device rules still apply in Northern Ireland.
Two honest gaps sit right here. The specific MHRA registration number for Morpheus8, and its UKCA or CE certificate details, could not be confirmed from a primary MHRA source: InMode runs a UK distribution channel, but a sales channel is not a registration record. And no MHRA safety alert specific to radiofrequency microneedling has been identified, with the Central Alerting System the authoritative place to check. The MHRA does act here when it decides to, having taken enforcement action on certain mechanical microneedling pens.
Now notice what none of that covers. Registration is about a product’s route to market, not anyone certifying that the treatment works, and it says nothing about the training of whoever picks the handpiece up. This device’s regulatory milestones are American and Canadian: cleared under the Morpheus8 name in December 2019, indications expanded in July 2023, another applicator cleared in June 2024. The paper trail is about a product, not a practitioner.
Green, amber, red: where Morpheus8 lands
Between 2 September and 28 October 2023 the Government consulted on licensing non-surgical cosmetic procedures in England, drawing over 11,800 responses. The scheme it proposed sorts procedures into three tiers.
| Tier | What the consultation response sets out |
|---|---|
| Green | The lowest risk group. Microneedling on its own sits here |
| Amber | Radiofrequency treatments, and hybrid devices combining two or more technologies. A non healthcare professional would need a licence with oversight by a named regulated healthcare professional; a regulated healthcare professional could perform it without that oversight |
| Red | These would become CQC regulated activities, requiring registered premises |
Morpheus8 is not left to interpretation there. The response names as amber the combination of 2 or more technologies to create a hybrid device, its chosen example being the combination of radiofrequency and microneedling to treat lines, wrinkles, sagging skin, acne scars and stretch marks. That is this treatment with the brand name taken off.
Pause on that. Microneedling alone is green. Radiofrequency alone is amber. Put the two in one handpiece and you stay amber, which is the Government agreeing with what marketing tends to blur: heat at depth is not a bonus bolted onto microneedling. It is a different procedure.
Amber would not bring a mandatory Level 7 qualification, though. Several respondents raised Level 7 for amber procedures, a level the JCCP’s competency framework defines as advanced practice, and the Government did not mandate it.
The response also proposed banning under 18s unless approved by a GMC registered doctor, aligning with the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021, a restriction 9,418 of 11,708 respondents, 80 percent, backed across all procedures.
Proposal, not law, and it matters which way you say it
Proposed: a three tier scheme, radiofrequency plus microneedling hybrids in amber, and a named regulated healthcare professional attached to every non healthcare professional performing them.
Law today: none of it. No scheme is in force, further consultation and Parliamentary time are still required, and the sources give no commencement date, so anyone quoting you a start date is telling you something they cannot know. The trade press covered the announcement in August 2025, which is where most of the new rules are coming headlines came from, and a headline is not a commencement.
Why the gap matters more for this device than for most
Licensing arguments can feel abstract. This one is not.
Morpheus8 isn’t FDA approved. It is 510(k) cleared, which sounds similar and is not: clearance means the paperwork showed the device was similar enough to something already on the market, not that it works. No Morpheus8 clearance names wrinkles, skin tightening, acne scars, cellulite, stretch marks, body contouring or fat reduction; the cleared wording covers electrocoagulation, haemostasis, and coagulation or contraction of soft tissue. Nobody at the MHRA has certified that it works either, because registration was never that kind of test.
On 15 October 2025 the FDA issued a safety communication about radiofrequency microneedling, reporting burns, scarring, fat loss, disfigurement, nerve damage and the need for surgical repair, and stating that it is a medical procedure, not a cosmetic treatment. Professional societies responded by advising practitioners to add those risks to consent forms.
The evidence underneath is thinner than the advertising suggests, too. No sham controlled randomised trial of Morpheus8 exists. The one systematic review that excluded industry funded studies rates the evidence base Level of Evidence 5, and names user error as the highest source of complication risk.
Read that last clause again: it is the argument for licensing in one line. The largest identified risk is not the machine. It is the person using it, and that is the part England does not yet regulate.
Scotland is proposing something noticeably stricter
Look north for contrast. Independent healthcare services in Scotland must already register with Healthcare Improvement Scotland, and running an unregistered one is a criminal offence. The Scottish Government’s June 2025 consultation response proposes three groups: microneedling to a depth of 1.5 mm and radiofrequency treatments in Group 1, licensed by the local authority; microneedling deeper than 1.5 mm, and any Group 1 or 2 procedure using an anaesthetic, in Group 3, restricted to a doctor, dentist, prescribing nurse or prescribing pharmacist. Morpheus8 runs at 1 to 7 mm and is typically performed under anaesthetic, so it lands in Group 3, healthcare professionals only. Also a proposal rather than law, with no published commencement date.
What you can check today, while the gap is still open
Regulation is slow. Your appointment is not. Ask these now, and a good clinic will answer without flinching.
- Who is holding the handpiece, and what are they registered as? Ask for the register and the number, then look it up yourself. This is the question the whole proposed scheme is built around.
- Is a regulated healthcare professional involved, and how? Nothing stops a clinic running the amber model voluntarily right now, with a named clinician overseeing a non-clinician operator. Plenty already do.
- What is the premises position with the council? Outside London that varies, and the answer is the council’s, not the clinic’s.
- What is on the consent form? Burns, scarring, fat loss, disfigurement, nerve damage and the possibility of needing surgical repair should all appear by name.
- What happens if something goes wrong? Who reviews you, how quickly, and at whose cost. Get that before you pay.
- Does the price make sense? A number well below everything else you have seen is telling you something, and what a cheap deal can be hiding is rarely advertised.
Separately, this treatment carries a real contraindication list, so whether you can have it at all is a clinical question, not an admin one. If something on your skin needs diagnosing rather than treating, see a GP or a dermatologist first.
None of this is a reason to panic about an appointment you have already made. It is a reason to ask better questions than the rules currently force anyone to answer. Book a consultation with us for the honest version: who would treat you, what they are registered as, what the device is and is not cleared for, and whether it is the right tool for what is bothering you.
At a glance
The proposed licensing scheme, weighed honestly
+ Reasons in favour
- It names this kind of treatment directly rather than leaving it to interpretation. The consultation response lists hybrid devices combining two or more technologies as amber, and gives radiofrequency plus microneedling as its own worked example
- Amber would put a named regulated healthcare professional into the picture whenever a non healthcare professional performs the procedure, which is not required anywhere in England today
- It targets the right risk. The one independent review that excluded industry funded studies names user error as the highest source of complication risk, and user error is exactly what a licence is designed to police
− Reasons for caution
- It is a proposal, not law. The powers have sat unused in the Health and Care Act 2022, further consultation and Parliamentary time are still required, and no source gives a commencement date
- Amber would not mandate a Level 7 qualification. Several respondents raised Level 7 for amber procedures and the Government did not require it, so a licence would not automatically mean advanced practice
- Regulating who holds the handpiece changes nothing about what the device is cleared for or how thin the evidence base is. A licensed operator is still performing a procedure with no cosmetic indication in any clearance
Frequently asked questions
The short version.
01Is Morpheus8 regulated in England right now?
The machine is, in a limited sense. The procedure is not. Medical devices placed on the Great Britain market must be registered with the MHRA, and a manufacturer based outside the UK has to appoint a UK Responsible Person. That is a route to market question, not a finding that the treatment works, and it says nothing about who operates the device. There is currently no national licensing scheme in force for non-surgical cosmetic procedures in England. The specific MHRA registration number and the UKCA or CE certificate details for Morpheus8 could not be confirmed from a primary MHRA source.
02Does the person treating me have to be a doctor or a nurse?
Not in England today. No national scheme sets an operator qualification level for radiofrequency microneedling, and the JCCP's paper on energy based devices recommends standardised training and adverse event reporting without setting one. Under the Government's amber proposals a non healthcare professional would need a licence with oversight by a named regulated healthcare professional, and a regulated healthcare professional could perform the procedure without that oversight. That is a proposal. It is not in force.
03What does amber actually mean in the proposed scheme?
Two things, and only these two. A non healthcare professional would need a licence with oversight by a named regulated healthcare professional. A regulated healthcare professional could perform the procedure without that oversight. Red tier procedures, which are a separate group, would become CQC regulated activities requiring registered premises. Microneedling on its own sits in the green tier as the lowest risk group, while radiofrequency treatments and hybrid devices combining two or more technologies sit in amber.
04Has the MHRA issued a safety alert about radiofrequency microneedling?
No MHRA safety alert specific to radiofrequency microneedling has been identified. The MHRA's Central Alerting System is the authoritative place to check, and the MHRA does act on this category of product when it decides to, having taken enforcement action on certain mechanical microneedling pens. The widely reported safety communication of 15 October 2025, which lists burns, scarring, fat loss, disfigurement, nerve damage and the need for surgical repair, came from the FDA rather than from a UK regulator.
05When does the England licensing scheme start?
Nobody can honestly tell you. The consultation ran from 2 September to 28 October 2023 and drew over 11,800 responses, the Government published its response, and the trade press covered the announcement in August 2025. Further consultation and Parliamentary time are still required before any scheme takes effect, and the sources give no commencement date. If a clinic quotes you a start date, ask where it came from.
